Rodman David Malcom bought MLYS
February 13, 2026 · Form 4 insider transaction
Rodman David Malcom bought 4,166 shares of Mineralys Therapeutics, Inc. at $14.25 per share, a transaction worth $59.4K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
4,166
Price
$14.25
Total value
$59.4K
InsiderRodman David Malcom
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 13, 2026
Filing dateFebruary 13, 2026
Shares owned after54,603
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025.